We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 462

  • Beijing Sanyou Intellectual Property Agency Ltd
  • China
  • September 11 2015


Experimental use exemption of patent infringement ̶ a brief comparison of China and the United States
  • Peksung Intellectual Property Ltd
  • China, USA
  • February 3 2015

Generally, the purpose of a patent is to award the patentee a limited market monopoly for disclosing his invention to the public. Experimental use of

Patent protection for medical uses and relevant judicial practice in China
  • Wan Hui Da Law Firm & Intellectual Property Agency
  • China
  • June 18 2014

The Supreme People's Court (hereinafter refers to as SPC) recently announced "2013 Top Ten Innovative Intellectual Property Cases of Chinese Court"

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds
  • Greenberg Traurig LLP
  • China
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'

China newsletter - summer 2013
  • Greenberg Traurig LLP
  • China, Macau
  • July 17 2013

For the purpose of fully implementing the spirit of the Eighteenth National Congress of the Communist Party of China and attracting more foreign

Life sciences: 2013 legal developments you need to know about
  • Mayer Brown LLP
  • China, European Union, France, USA
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court

Changing trends in patent protection for the pharma industry
  • Heskia - Hacmun Law Firm
  • China, India, Israel
  • June 6 2013

This April India's Supreme Court oversaw a high profile case involving Novartis' patent application for Glivec, a cancer-battling medication

Insights on drafting pharmaceutical patents from the “Supreme People’s Court’s Annual Report of Intellectual Property Cases”
  • King & Wood Mallesons
  • China
  • May 31 2013

In April 2013, the Supreme People's Court ("SPC") issued the"Supreme People's Court's Annual Report of Intellectual Property Cases", in which the SPC

Overview of patent-statutory subject matter in biotechnology
  • CCPIT Patent & Trademark Law Office
  • China, European Union, Japan, USA
  • April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

The Patent Reexamination Board makes a clear explanation about whether the invention relating to embryonic stem cells is contrary to the social morality or not
  • Wan Hui Da Law Firm & Intellectual Property Agency
  • China
  • March 29 2013

Reexamination Board (PRB) on this case provides the guidance for the judgment on whether the invention relating to embryonic stem cells is contrary